High-grade serous ovarian cancer: Basic sciences, clinical and therapeutic standpoints
作者： Michael-Antony Lisio , Lili Fu , Alicia Goyeneche , Zu-hua Gao , Carlos Telleria
DOI: 10.3390/IJMS20040952
关键词:
摘要: Among a litany of malignancies affecting the female reproductive tract, that of the ovary is the most frequently fatal. Moreover, while the steady pace of scientific discovery has fuelled …
mdpi.com
mendeley.com参考文章(159)
Silvana Canevari, M Onofriescu, M Danciu, Irina Draga Căruntu, Maria Luisa Carcangiu, Cornelia Amălinei, Ludmila Liliac, Delia Gabriela Ciobanu Apostol, The value of PAX8 and WT1 molecules in ovarian cancer diagnosis. Romanian Journal of Morphology and Embryology. ,vol. 54, pp. 17- 27 ,(2013)
, Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls The Lancet. ,vol. 371, pp. 303- 314 ,(2008) , 10.1016/S0140-6736(08)60167-1
Joan L. Walker, C. Bethan Powell, Lee-may Chen, Jeanne Carter, Victoria L. Bae Jump, Lynn P. Parker, Mark E. Borowsky, Randall K. Gibb, Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer Cancer. ,vol. 121, pp. 2108- 2120 ,(2015) , 10.1002/CNCR.29321
Zachary C. Dobbin, Ashwini A. Katre, Adam D. Steg, Britt K. Erickson, Monjri M. Shah, Ronald D. Alvarez, Michael G. Conner, David Schneider, Dongquan Chen, Charles N. Landen, Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer Oncotarget. ,vol. 5, pp. 8750- 8764 ,(2014) , 10.18632/ONCOTARGET.2373
, Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies The Lancet. ,vol. 385, pp. 1835- 1842 ,(2015) , 10.1016/S0140-6736(14)61687-1
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. ,vol. 136, ,(2015) , 10.1002/IJC.29210
Russell Vang, Douglas A. Levine, Robert A. Soslow, Charles Zaloudek, Ie-Ming Shih, Robert J. Kurman, Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study. International Journal of Gynecological Pathology. ,vol. 35, pp. 48- 55 ,(2016) , 10.1097/PGP.0000000000000207
Cheryl A Sherman-Baust, Elisabetta Kuhn, Blanca L Valle, Ie-Ming Shih, Robert J Kurman, Tian-Li Wang, Tomokazu Amano, Minoru SH Ko, Ichiro Miyoshi, Yoshihiko Araki, Elin Lehrmann, Yongqing Zhang, Kevin G Becker, Patrice J Morin, A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development. The Journal of Pathology. ,vol. 233, pp. 228- 237 ,(2014) , 10.1002/PATH.4353
K Swenerton, J Jeffrey, G Stuart, M Roy, G Krepart, J Carmichael, P Drouin, R Stanimir, G O'Connell, G MacLean, Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology. ,vol. 10, pp. 718- 726 ,(1992) , 10.1200/JCO.1992.10.5.718
P Francis, E Rowinsky, J Schneider, T Hakes, W Hoskins, M Markman, Phase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: a Gynecologic Oncology Group pilot Study. Journal of Clinical Oncology. ,vol. 13, pp. 2961- 2967 ,(1995) , 10.1200/JCO.1995.13.12.2961